Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells

Journal of Immunology

Volumn 185, Issue 1, 2010, Pages 183-189

  Toulza, Frederic ^a   Nosaka, Kisato ^c   Tanaka, Yuetsu ^d   Schioppa, Tiziana ^b   Balkwill, Frances ^b   Taylor, Graham P ^a   Bangham, Charles R M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR4; MACROPHAGE DERIVED CHEMOKINE; TAX PROTEIN; TRANSCRIPTION FACTOR FOXP3; CCL22 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL KILLING; CELL MIGRATION; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; IN VITRO STUDY; INFLAMMATORY DISEASE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL LEUKEMIA; VIRUS CELL INTERACTION; VIRUS INFECTION; BIOSYNTHESIS; BLOOD; CD4 LYMPHOCYTE COUNT; CELL PROLIFERATION; CYTOLOGY; CYTOTOXICITY TEST; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGY; LEUKEMIA CELL LINE; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

CD4 LYMPHOCYTE COUNT; CELL PROLIFERATION; CELL SURVIVAL; CHEMOKINE CCL22; CYTOTOXICITY TESTS, IMMUNOLOGIC; FORKHEAD TRANSCRIPTION FACTORS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JURKAT CELLS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY;

EID: 77956194454     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903846     Document Type: Article

References (44)

1. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet 1: 1031-1032. (Pubitemid 16102987)
2. Nagai, M., and M. Osame. 2003. Human T-cell lymphotropic virus type I and neurological diseases. J. Neurovirol. 9: 228-235. (Pubitemid 36656456)
3. Uchiyama, T., J. Yodoi, K. Sagawa, K. Takatsuki, and H. Uchino. 1977. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50: 481-492.
4. Miyoshi, I., I. Kubonishi, S. Yoshimoto, T. Akagi, Y. Ohtsuki, Y. Shiraishi, K. Nagata, and Y. Hinuma. 1981. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294: 770-771.
5. Kalyanaraman, V. S., M. G. Sarngadharan, Y. Nakao, Y. Ito, T. Aoki, and R. C. Gallo. 1982. Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc. Natl. Acad. Sci. USA 79: 1653-1657.
6. Cross, S. L., M. B. Feinberg, J. B. Wolf, N. J. Holbrook, F. Wong-Staal, and W. J. Leonard. 1987. Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell 49: 47-56.
7. Hanon, E., P. Goon, G. P. Taylor, H. Hasegawa, Y. Tanaka, J. N. Weber, and C. R. Bangham. 2001. High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood 98: 721-726.
8. Abe, M., K. Uchihashi, T. Kazuto, A. Osaka, K. Yanagihara, K. Tsukasaki, H. Hasegawa, Y. Yamada, and S. Kamihira. 2008. Foxp3 expression on normal and leukemic CD4+CD25+ T cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells. Eur. J. Haematol. 81: 209-217.
9. Toulza, F., K. Nosaka, M. Takiguchi, T. Pagliuca, H. Mitsuya, Y. Tanaka, G. P. Taylor, and C. R. Bangham. 2009. FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia. Int. J. Cancer 125: 2375-2382.
10. Bach, J. F. 2003. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3: 189-198.
11. Fontenot, J. D., and A. Y. Rudensky. 2005. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6: 331-337.
12. Hirahara, K., L. Liu, R. A. Clark, K. Yamanaka, R. C. Fuhlbrigge, and T. S. Kupper. 2006. The majority of human peripheral blood CD4+CD25high-Foxp3+ regulatory T cells bear functional skin-homing receptors. J. Immunol. 177: 4488-4494.
13. Gobert, M., I. Treilleux, N. Bendriss-Vermare, T. Bachelot, S. Goddard-Leon, V. Arfi, C. Biota, A. C. Doffin, I. Durand, D. Olive, et al. 2009. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 69: 2000-2009.
14. Qin, X. J., H. Z. Shi, J. M. Deng, Q. L. Liang, J. Jiang, and Z. J. Ye. 2009. CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin. Cancer Res. 15: 2231-2237.
15. Mizukami, Y., K. Kono, Y. Kawaguchi, H. Akaike, K. Kamimura, H. Sugai, and H. Fujii. 2008. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer. Int. J. Cancer 122: 2286-2293.
16. Cao, Y., J. Zhao, Z. Lei, S. Shen, C. Liu, D. Li, J. Liu, G. X. Shen, G. M. Zhang, Z. H. Feng, and B. Huang. 2008. Local accumulation of FOXP3+ regulatory T cells: evidence for an immune evasion mechanism in patients with large condylomata acuminata. J. Immunol. 180: 7681-7686.
17. Ohara, M., Y. Yamaguchi, K. Matsuura, S. Murakami, K. Arihiro, and M. Okada. 2009. Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer. Cancer Immunol. Immunother. 58: 441-447.
18. Lee, I., L. Wang, A. D. Wells, M. E. Dorf, E. Ozkaynak, and W. W. Hancock. 2005. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201: 1037-1044.
19. Kohno, T., Y. Yamada, N. Akamatsu, S. Kamihira, Y. Imaizumi, M. Tomonaga, and T. Matsuyama. 2005. Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. Cancer Sci. 96: 527-533. (Pubitemid 41387306)
20. Toulza, F., A. Heaps, Y. Tanaka, G. P. Taylor, and C. R. Bangham. 2008. High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood 111: 5047-5053.
21. Montes, M., C. Sanchez, K. Verdonck, J. E. Lake, E. Gonzalez, G. Lopez, A. Terashima, T. Nolan, D. E. Lewis, E. Gotuzzo, and A. C. White, Jr. 2009. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl. Trop. Dis. 3: e456.
22. Hieshima, K., D. Nagakubo, T. Nakayama, A. K. Shirakawa, Z. Jin, and O. Yoshie. 2008. Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells. J. Immunol. 180: 931-939.
23. Yoshie, O., R. Fujisawa, T. Nakayama, H. Harasawa, H. Tago, D. Izawa, K. Hieshima, Y. Tatsumi, K. Matsushima, H. Hasegawa, et al. 2002. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 99: 1505-1511.
24. Shimoyama, M. 1991. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br. J. Haematol. 79: 428-437.
25. Lee, B., Y. Tanaka, and H. Tozawa. 1989. Monoclonal antibody defining tax protein of human T-cell leukemia virus type-I. Tohoku J. Exp. Med. 157: 1-11.
26. Nagai, M., K. Usuku, W. Matsumoto, D. Kodama, N. Takenouchi, T. Moritoyo, S. Hashiguchi, M. Ichinose, C. R. Bangham, S. Izumo, and M. Osame. 1998. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J. Neurovirol. 4: 586-593.
27. Tosswill, J. H., G. P. Taylor, J. P. Clewley, and J. N. Weber. 1998. Quantification of proviral DNA load in human T-cell leukaemia virus type I infections. J. Virol. Methods 75: 21-26.
28. Hanon, E., S. Hall, G. P. Taylor, M. Saito, R. Davis, Y. Tanaka, K. Usuku, M. Osame, J. N. Weber, and C. R. Bangham. 2000. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95: 1386-1392.
29. Imai, T., D. Chantry, C. J. Raport, C. L. Wood, M. Nishimura, R. Godiska, O. Yoshie, and P. W. Gray. 1998. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 273: 1764-1768.
30. Zou, W. 2006. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6: 295-307.
31. Gallimore, A., and A. Godkin. 2008. Regulatory T cells and tumour immunity - observations in mice and men. Immunology 123: 157-163.
32. Yang, Z. Z., A. J. Novak, M. J. Stenson, T. E. Witzig, and S. M. Ansell. 2006. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107: 3639-3646.
33. Mempel, T. R., M. J. Pittet, K. Khazaie, W. Weninger, R. Weissleder, H. von Boehmer, and U. H. von Andrian. 2006. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25: 129-141.
34. Niewiesk, S., S. Daenke, C. E. Parker, G. Taylor, J. Weber, S. Nightingale, and C. R. Bangham. 1994. The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J. Virol. 68: 6778-6781.
35. Jeffery, K. J., K. Usuku, S. E. Hall, W. Matsumoto, G. P. Taylor, J. Procter, M. Bunce, G. S. Ogg, K. I. Welsh, J. N. Weber, et al. 1999. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl. Acad. Sci. USA 96: 3848-3853.
36. Vine, A. M., A. D. Witkover, A. L. Lloyd, K. J. Jeffery, A. Siddiqui, S. E. Marshall, M. Bunce, N. Eiraku, S. Izumo, K. Usuku, et al. 2002. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-Iassociated myelopathy/tropical spastic paraparesis. J. Infect. Dis. 186: 932-939.
37. Vine, A. M., A. G. Heaps, L. Kaftantzi, A. Mosley, B. Asquith, A. Witkover, G. Thompson, M. Saito, P. K. Goon, L. Carr, et al. 2004. The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J. Immunol. 173: 5121-5129.
38. Asquith, B., A. J. Mosley, A. Barfield, S. E. Marshall, A. Heaps, P. Goon, E. Hanon, Y. Tanaka, G. P. Taylor, and C. R. Bangham. 2005. A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J. Gen. Virol. 86: 1515-1523.
39. Kattan, T., A. MacNamara, A. G. Rowan, H. Nose, A. J. Mosley, Y. Tanaka, G. P. Taylor, B. Asquith, and C. R. Bangham. 2009. The avidity and lytic efficiency of the CTL response to HTLV-1. J. Immunol. 182: 5723-5729.
40. Bangham, C. R. 2009. CTL quality and the control of human retroviral infections. Eur. J. Immunol. 39: 1700-1712.
41. Ishida, T., T. Ishii, A. Inagaki, H. Yano, S. Kusumoto, M. Ri, H. Komatsu, S. Iida, H. Inagaki, and R. Ueda. 2006. The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma. Leukemia 20: 2162-2168. (Pubitemid 44782842)
42. Ishida, T., and R. Ueda. 2006. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci. 97: 1139-1146. (Pubitemid 44430638)
43. Norrgren, H. R., S. Bamba, O. Larsen, Z. Da Silva, P. Aaby, T. Koivula, and S. Andersson. 2008. Increased prevalence of HTLV-1 in patients with pulmonary tuberculosis coinfected with HIV, but not in HIV-negative patients with tuberculosis. J. Acquir. Immune Defic. Syndr. 48: 607-610.
44. Oliveira, Mde. F., C. Brites, N. Ferraz, P. Magalhaes, F. Almeida, and A. L. Bittencourt. 2005. Infective dermatitis associated with the human T cell lymphotropic virus type I in Salvador, Bahia, Brazil. Clin. Infect. Dis. 40: e90-e96.